Eugene Buchwald
Neurology · Edison, NJNPI 1588724777
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 72 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 11.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $714 and has fallen 94.9% since, to $36 in 2023. That places this record below the midpoint for neurology clinicians in NJ, where the typical reported total is $1,560.
Across 72 payments — averaging $15.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$121
- Biogen$103
- Novartis$70
- AstraZeneca$60
- Sunovion Pharmaceuticals Inc.$50
- Mallinckrodt Enterprises LLC$48
- plus $633 from 25 others
What the payments were for
- Speaking & faculty fees$151%
- Food & beverage$1,06999%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EMD Serono, Inc. | 8 | $121 |
| Biogen | 7 | $103 |
| Novartis | 4 | $70 |
| AstraZeneca | 4 | $60 |
| Sunovion Pharmaceuticals Inc. | 3 | $50 |
| Mallinckrodt Enterprises LLC | 3 | $48 |
| Amgen | 3 | $48 |
| UCB, Inc. | 3 | $44 |
| Kyowa Kirin, Inc. | 3 | $43 |
| Avanir Pharmaceuticals, Inc. | 3 | $40 |
| AbbVie | 3 | $40 |
| Boston Scientific | 1 | $36 |
| Bristol Myers Squibb | 2 | $34 |
| Akcea Therapeutics, Inc. | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Sanofi | 2 | $29 |
| Supernus Pharmaceuticals, Inc. | 2 | $28 |
| Acadia Pharmaceuticals Inc | 2 | $27 |
| Lilly USA, LLC | 2 | $26 |
| Aprecia Pharmaceuticals, LLC | 2 | $24 |
| Adamas Pharmaceuticals, Inc. | 1 | $15 |
| Neurocrine Biosciences, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| Acorda Therapeutics, Inc | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $15 |
| Grifols USA, LLC | 1 | $14 |
| Amneal Pharmaceuticals LLC | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| GE HealthCare | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Eisai Inc. | 1 | $12 |
How this compares
$1,084 in reported general payments places this provider in the 45th percentile of 521 neurology providers in New Jersey.
Other neurology in Edison
- Marina SobolEdison$69K
- Igor SobolEdison$55K
- Wei Wei MaEdison$39K
- Steven BromleyAudubon$1.5M
- Mary Ann PiconeTeaneck$1.5M
- Fiona GuptaOradell$1.1M
- Matthew DavisMiddletown$567K
- Amos KatzEatontown$558K
- Monte PellmarFreehold$429K
- Marcie RabinSummit$387K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.